Pfizer, BioNTech Seek Full FDA Approval For Covid Vaccine; Shares Pop<blockquote>辉瑞、BioNTech 寻求 FDA 对 Covid 疫苗的全面批准;股票流行</blockquote>
Pfizer and BioNTech asked for full Food and Drug Administration approval of their Covid vaccine on Friday, leading BioNTech stock to pop. That followed patent questions that hurt shares.